ANTERIS TECHNOLOGIES
Anteris Technologies is a structural heart company focused on developing innovative & durable health solutions.
ANTERIS TECHNOLOGIES
Industry:
Biotechnology Health Care Medical
Founded:
2006-01-01
Address:
Toowong, Queensland, Australia
Country:
Australia
Website Url:
http://www.anteristech.com
Total Employee:
51+
Status:
Active
Contact:
+61 1300 550 310
Total Funding:
34.29 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon LetsEncrypt Amazon SSL By Default HSTS ReCAPTCHA
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Anteris Technologies
L1 Capital
L1 Capital investment in Post-IPO Equity - Anteris Technologies
Partners for Growth
Partners for Growth investment in Post-IPO Debt - Anteris Technologies
Official Site Inspections
http://www.anteristech.com Semrush global rank: 4.6 M Semrush visits lastest month: 2.1 K
- Host name: 151.101.131.10
- IP address: 151.101.131.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Anteris Technologies"
Learn about Anteris Technologies - aem-dev.anteristech.com
Our story began 40 years ago, after physicians realized that commercially available animal-based tissues were calcifying. 1 Through decades of experimental surgical research, physicians and …See details»
Latest News & Events from Anteris Technologies
May 29, 2024 21 Nov 2023. Anteris Reports Outstanding 30-Day Haemodynamic Results from the DurAVRâ„¢ THV US EFS Trial. Anteris reports 30-day data from the US Early Feasibility Study (EFS) for DurAVRâ„¢ …See details»
Anteris Technologies - LinkedIn
Anteris Technologies Medical Equipment Manufacturing Eagan, MN 6,165 followers Anteris Technologies is a structural heart company focused on developing innovative & durable health solutions.See details»
Contact - Anteris Tech
Registered and Principal Office. Toowong Tower, Level 3, Suite 302. 9 Sherwood Road. Toowong, QLD 4066. Australia Contact Details. T +61 1300 550 310 | +61 7 3152 3200See details»
Anteris Technologies | LinkedIn
Anteris Technologies | 6.164 Follower:innen auf LinkedIn. Anteris Technologies is a structural heart company focused on developing innovative & durable health solutions. | Anteris …See details»
Anteris Technologies - YouTube
Anteris Technologies is a structural heart company delivering clinically superior solutions that fill significant unmet clinical needs in the global market. Anteris’ DurAVRâ„¢ THV is the first ...See details»
Anteris Technologies and v2vmedtech Announce Concept Lock of …
Jul 1, 2024 BRISBANE, Australia & EAGAN, Minn., July 01, 2024--Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVRâ„¢ THV, a new class of TAVR and …See details»
Share and Option Schemes of Arrangement and ... - Anteris Tech
2 days ago Important Update. Anteris Technologies Ltd has announced that the Supreme Court of Queensland has today made orders approving the dispatch of the supplementary scheme …See details»
Anteris Technologies Receives FDA Clearance to Initiate Early ...
Nov 28, 2022 Investor contact Deanne Curry GRACosway E: [email protected] M: +61 414 388 997 Media contact Nick Howe GRACosway [email protected] M: +61 407 …See details»
Anteris Technologies (@AnterisTech) / Twitter
Oct 25, 2013 At #Anteristech, we’re focused on equity, diversity, and inclusion all year round. Today, we’re celebrating International Women’s Day #IWD2023 #EmbraceEquity by …See details»
Anteris Technologies and v2vmedtech Announce Concept Lock of …
Jul 1, 2024 Investor Relations [email protected] Anteris Technologies Ltd +61 1300 550 310 | +61 7 3152 3200 Investor Relations (US) Malini Chatterjee, PhD.See details»
Anteris Technologies - Facebook
Anteris Technologies. 4 likes. Structural heart company focused on engineering innovative & durable health solutions (ASX: AVR)See details»
Anteris Technologies ASX: AVR Investor Page
To receive exercise form and details on the payment submission process, contact [email protected] For any general questions related to holders of unlisted …See details»
Anteris Technologies - LinkedIn
Anteris Technologies | 6,188 followers on LinkedIn. Anteris Technologies is a structural heart company focused on developing innovative & durable health solutions. | Anteris …See details»
Anteris Technologies Commences US Early Feasibility Study
Aug 9, 2023 Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVRâ„¢ Transcatheter Heart Valve (THV), a new class ofSee details»
Innovative Heart Valve Technologies | Anteris Technologies
DurAVRâ„¢ THV is a novel first-in-class biomimetic valve made from a single piece of native-shaped tissue.It’s designed to mimic the performance of a pre-disease human aortic valve. …See details»
Anteris Technologies Commences American Depository Receipt …
Aug 9, 2023 DurAVRâ„¢ Transcatheter Heart Valve developed by Anteris Technologies. The company has established an American Depositary Receipt (ADR) program to improve U.S. …See details»
Unlocking Biotechnology Investment Potential: Anteris ADR …
Jul 1, 2024 Discover the promising investment potential in the field of biotechnology with Anteris Technologies Ltd. Explore the convenience of Anteris' sponsored Level 1 American Depositary …See details»
Anteris Technologies Announces First Successful ... - Business Wire
Jul 31, 2023 Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVRâ„¢ THV, a new class of biomimetic heart valvSee details»